MATERIALS AND METHODS FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS

摘要

Materials and methods for treating a patient with Transthyretin Amyloidosis, both ex vivo and in vivo, are provided, and materials and methods for modulating the expression, function, or activity of a Transthyretin (TTR) gene in a cell by genome editing are provided.